REVLIMID lenalidomide 7.5mg capsule blister pack

Bristol-Myers Squibb Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e1ac786f9f303c54
Product Name: REVLIMID lenalidomide 7.5mg capsule blister pack
Artg Id: 229851
Artg Name: REVLIMID lenalidomide 7.5mg capsule blister pack
Sponsor: Bristol-Myers Squibb Australia Pty Ltd
Company Detail Path: /organization/bristol-myers-squibb-australia-pty-ltd
Artg Date: 2015-11-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/1fee684bd6de3174cd01fbcce459a970.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/f0d4d76b1916181f19551fd98e4d5723.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

e1ac786f9f303c54

Type

Standard